Back

SARS-CoV-2 escapes CD8 T cell surveillance via mutations in MHC-I restricted epitopes

Agerer, B.; Koblischke, M.; Gudipati, V.; Smyth, M.; Popa, A.; Genger, J.-W.; Endler, L.; Florian, D. M.; Muehlgrabner, V.; Lercher, A.; Gattinger, P.; Torralba-Gombau, R.; Penz, T.; Fae, I.; Wenda, S.; Traungott, M.; Walder, G.; Fischer, G.; Hoepler, W.; Pawelka, E.; Zoufaly, A.; Valenta, R.; Bock, C.; Huppa, J. B.; Aberle, J. H.; Bergthaler, A.

2020-12-20 immunology
10.1101/2020.12.18.423507 bioRxiv
Show abstract

CD8+ T cell immunity to SARS-CoV-2 has been implicated in COVID-19 severity and virus control, though direct evidence has been lacking so far. Here, we identified non-synonymous mutations in MHC-I restricted CD8+ T cell epitopes after deep sequencing of 747 SARS-CoV- 2 virus isolates. Mutant peptides exhibited diminished or abrogated MHC-I binding, which was associated with a loss of recognition and functional responses by CD8+ T cells isolated from HLA-matched COVID-19 patients. Our findings highlight the capacity of SARS-CoV-2 to subvert CD8+ T cell surveillance through escape mutations in MHCI-restricted viral epitopes. This provides evolutionary evidence for CD8+ T cell immunity controlling SARS-CoV-2 with consequences for COVID-19 vaccine design.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.